Innate immune activation in neurodegenerative disease
The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Abstract
The triggering of innate immune mechanisms is emerging as a crucial component of major neurodegenerative diseases. Microglia and other cell types in the brain can be activated in response to misfolded proteins or aberrantly localized nucleic acids. This diverts microglia from their physiological and beneficial functions, and leads to their sustained release of pro-inflammatory mediators. In this Review, we discuss how the activation of innate immune signalling pathways - in particular, the NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome - by aberrant host proteins may be a common step in the development of diverse neurodegenerative disorders. During chronic activation of microglia, the sustained exposure of neurons to pro-inflammatory mediators can cause neuronal dysfunction and contribute to cell death. As chronic neuroinflammation is observed at relatively early stages of neurodegenerative disease, targeting the mechanisms that drive this process may be useful for diagnostic and therapeutic purposes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is corollary evidence for inflammation in FTD (Heneka et al., 2014), from genetic (Guerreiro et al., 2013; Rayaprolu et al., 2013; Broce et al., 2018), CSF (Sjogren et al., 2004; Woollacott et al., 2018), epidemiology (Miller et al., 2013, 2016), post-mortem (Venneti et al., 2008; Lant et al., 2014) and animal studies (Yoshiyama et al., 2007; Bhaskar et al., 2010; Yin et al., 2010).”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Heneka et al., 2014
In the citing paper
“in AD, the chronic release of DAMPs, mitochondrial-released DAMPs and pro-inflammatory molecules contributes to the onset and progression of neurodegeneration [57, 76, 97, 149, 194, 270, 304, 333, 345]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“This is thought to divert microglia from performing house-keeping functions, promoting a low-grade inflammatory state and CNS damage [149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“studies have shown that cellular aging, infection, traumatic brain injury, systemic inflammation, chronic inflammatory diseases, obesity and poor oral health occurring during middle adulthood can lead to increased pro-inflammatory signals in the periphery, which may contribute to glial activation and the onset and/or perpetuation of neurodegeneration [93, 105, 149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“TLRs and associated signaling pathways contribute to both injurious and regenerative processes in CNS diseases (33–35).”
From UNC93B1 Is Widely Expressed in the Murine CNS and Is Required for Neuroinflammation and Neuronal Injury Induced by MicroRNA let-7b (2021) · cites this paper as [33]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Cited by
Items 401–500 of 1,004
Role of the mitochondrial stress response in human cancer progression
Wang, S., Chen, S., Tseng, L., & Lee, H. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220920558 · Cited by 54
“diseases, such as autoimmune disorders, gout, osteoarthritis, Alzheimer’s disease, type 2 diabetes, atherosclerosis, lupus, macular degeneration, and cancer.(185,186) Circulating mtDNA inhibited the production of proinflammatory cytokines, horizontal transfer of mtDNA from tumor cells to surrounding immune cell-activa…”
BackgroundRps27a might act as a controller of microglia activation in triggering neurodegenerative diseases
Khayer, N., Mirzaie, M., Marashi, S., & Jalessi, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239219 · Cited by 55
Psychobiotics and the Microbiota–Gut–Brain Axis: Where Do We Go from Here?
Binda, S., Tremblay, A., Iqbal, U., Kassem, O., Barz, M. L., Thomas, V., Bronner, S., Perrot, T. S., Ismail, N., & Parker, J. A. (2024) · Microorganisms · doi:10.3390/microorganisms12040634 · Cited by 70
“Progranulin deficiency leads to an imbalanced inflammatory response, suggesting that neuroinflammation isn’t merely a secondary effect but integral to disease pathogenesis [95].”
BackgroundThe biomarkers of immune dysregulation and inflammation response in Parkinson disease
Chen, L., Mo, M., Li, G., Cen, L., Wei, L., Xiao, Y., Chen, X., Li, S., Yang, X., Qu, S., et al. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0063-3 · Cited by 53
“If the proteasomes function are impaired in DA neurons, α-synuclein accumulation could activate the iproteasomeas as compensatory to provide much more MHC-I and MHC-II molecules to CDT and CD T cells showing stronger immune response [29, 32].”
BackgroundCoexistence of Multiple Sclerosis and Alzheimer's disease: A review
Luczynski, P., Laule, C., Hsiung, G.-Y. R., Moore, G. R. W., & Tremlett, H. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.10.109 · Cited by 50
The role of melatonin in targeting cell signaling pathways in neurodegeneration
Shukla, M., Chinchalongporn, V., Govitrapong, P., & Reiter, R. J. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14005 · Cited by 53
Özdal, Z. D., Şahmetlioğlu, E., Narin, İ., & Cumaoğlu, A. (2019) · 3 Biotech · doi:10.1007/s13205-019-1739-z · Cited by 51
Neuroimaging and biomarker evidence of neurodegeneration in asthma
Rosenkranz, M. A., Dean, D., Bendlin, B. B., Jarjour, N. N., Esnault, S. J., Zetterberg, H., Heslegrave, A., Evans, M. D., Davidson, R. J., & Busse, W. W. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.09.010 · Cited by 52
Zhu, S., Guo, J., Li, J.-Y., Dai, X., Li, X., & Li, J. (2021) · Food & Function · doi:10.1039/d1fo02857j · Cited by 50
Pike, A. F., Szabó, I., Veerhuis, R., & Bubacco, L. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00293-z · Cited by 52
“substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.”
BackgroundCanepa, E., Parodi‐Rullán, R. M., Vázquez‐Torres, R., Gamallo‐Lana, B., Guzman‐Hernandez, R. A., Lemon, N. L., Angiulli, F., Debure, L., Ilies, M. A., Østergaard, L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13063 · Cited by 56
“16 astrocytes and microglia are essential for the removal of Aβ through phagocytosis and degradation, which, when efficient, prevent Aβ accumulation [86-89] .”
BackgroundAlexander, C., Parsaee, A., & Vasefi, M. (2023) · Biology · doi:10.3390/biology12111453 · Cited by 62
“…accumulate in the brain due to impaired clearance [84], overzealous astrocytic and microglial responses compound the neuroin fl ammatory environment by releasing pro-in fl ammatory factors, promoting neuronal apoptosis [6,49,85–89]. pro-inflammatory factors, promoting neuronal apoptosis [6,49,85–89].”
BackgroundReus, G. Z., de Moura, A. B., Silva, R. H., Resende, W. R., & Quevedo, J. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170630164715 · Cited by 49
Oikonomidi, A., Tautvydaitė, D., Gholam‐Rezaee, M., Henry, H., Bacher, M., & Popp, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170335 · Cited by 51
“…the production of nitric oxide and several inflammatory cytokines including TNF-(cid:4) , IL-1 (cid:2) , IL-6, and IFN-(cid:5) , which in turn are known to have deleterious effects on the neuronal function and to contribute to the development of both amyloid pathology and neurodegeneration [31].”
Chen, G., Liu, J., Jiang, L., Ran, X., He, D., Li, Y., Huang, B., Wang, W., Liu, D., & Fu, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030821 · Cited by 52
“Although this view was initially met with scepticism, aberrant inflammatory responses in the CNS are now accepted to contribute to neuronal dysfunction [29].”
BackgroundXue, J., Yu, Y., Zhang, X., Zhang, C., Zhao, Y., Liu, B., Zhang, L., Wang, L., Chen, R., Gao, X., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012885 · Cited by 52
“These results suggested that SMS2 deficiency might inhibitmicroglia activation, and thus suppress Gal-3 production, subsequently attenuating the initiation of inflammatory response during cerebral I/R. SMS2 Deficiency Attenuated the Activation of TLR4/NF-jB Signaling Pathway After Cerebral I/R In several neurodegenera…”
BackgroundInfluentialJackson, L., Dumanli, S., Johnson, M. H., Fagan, S. C., & Ergul, A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01815-3 · Cited by 50
Mangiatordi, G. F., Intranuovo, F., Delre, P., Abatematteo, F. S., Abate, C., Niso, M., Creanza, T. M., Ancona, N., Stefanachi, A., & Contino, M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01357 · Cited by 52
Nakano-Kobayashi, A., Fukumoto, A., Morizane, A., Nguyen, D. T., Le, T. M., Hashida, K., Hosoya, T., Takahashi, R., Takahashi, J. B., Hori, O., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc1428 · Cited by 52
“(D) Graphic abstract: Upon injury or exposure to neuroinflammatory pathogens (1), microglia are activated and release cytokines and ROS (2), which triggers neuronal degeneration (3) (“neuroinflammation”).”
BackgroundDong, H., Zhang, X., Duan, Y., He, Y., Zhao, J., Wang, Z., Wang, J., Li, Q., Fan, G., Liu, Z., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03070-2 · Cited by 49
Bachstetter, A. D., Webster, S. J., Goulding, D. S., Morton, J. E., Watterson, D. M., & Van Eldik, L. J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0289-5 · Cited by 49
“responses in the brain, termed neuroinflammation (for recent reviews, see [5,6]).”
Nitric Oxide Inhibitory Meroterpenoids from the Fungus Penicillium purpurogenum MHZ 111
Sun, J., Zhu, Z., Song, Y., Dong, D., Zheng, J., Liu, T., Zhao, Y., Ferreira, D., Zjawiony, J. K., Tu, P., et al. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00160 · Cited by 54
Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase
Jiang, L., Wu, X., Wang, S., Chen, S., Zhou, H., Wilson, B. C., Jin, C., Lu, R., Xie, K., Wang, Q., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0573-z · Cited by 50
“” It is now widely accepted that dysregulated neuroinflammation featured by microglial over-activation has significant impacts on the pathogenesis of neurodegenerative disorders such as Parkinson’s disease (PD) [15, 16] and Alzheimer’s disease (AD) [17–21].”
BackgroundBrain inflammasomes in stroke and depressive disorders: Regulation by oestrogen
Slowik, A., Lammerding, L., Hoffmann, S., & Beyer, C. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12482 · Cited by 51
Gargouri, B., Yousif, N. M., Bouchard, M., Fetoui, H., & Fiebich, B. L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1198-1 · Cited by 52
A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer’s Disease
O’Bryant, S. E., Zhang, F., Johnson, L. A., Hall, J., Edwards, M., Grammas, P., Oh, E., Lyketsos, C. G., & Rissman, R. A. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180619 · Cited by 49
“Profiling biological pathways associated with neurodegenerative disease has been posited to highlight novel pathways for therapeutics[9, 10], with inflammation being a major implicated pathway[11, 12].”
Garcez, M. L., Jacobs, K. R., & Guillemin, G. J. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00057-3 · Cited by 53
Focke, C., Blume, T., Zott, B., Shi, Y., Deussing, M., Peters, F., Schmidt, C., Kleinberger, G., Lindner, S., Gildehaus, F.-J., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.217703 · Cited by 48
“At first glance, our findings seem at odds with findings of neuronal dysfunction arising from exposure of neurons to proinflammatory mediators during chronic microglial activation (7).”
BackgroundInfluentialMellesmoen, A., Sheeler, C. A., Ferro, A., Rainwater, O., & Cvetanović, M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00509 · Cited by 48
“, 2018), another phenomenon that is ubiquitously present in these diseases (Ilieva et al., 2009; Heneka et al., 2014; Pekny et al., 2016).”
BackgroundFellner, A., Barhum, Y., Angel, A., Perets, N., Steiner, I., Offen, D., & Lev, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081666 · Cited by 56
“Accumulating evidence implies that inflammatory response may play a significant role in motor neuron injury pathogenesis in ALS [6,12,20], and the innate immune system has been found to contribute to this process [6,20].”
BackgroundMicroglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies
Asraf, K., Torika, N., Apte, R. N., & Fleisher-Berkovich, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00116 · Cited by 48
“Reactive oxygen species (ROS), nitric oxide (NO) and elevated levels of inducible nitric oxide synthase (iNOS) enzyme, originating from resident CNS glial cells, are also observed during AD (Heneka et al., 2014).”
BackgroundModerate exercise induces trained immunity in macrophages
Murugathasan, M., Jafari, A., Amandeep, A., Hassan, S. A., Chihata, M., & Sater, A. A. A. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00130.2023 · Cited by 55
Time-dependent dual effect of microglia in ischemic stroke
Fan, P., Wang, S., Chu, S., & Chen, N. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105584 · Cited by 55
Blossom, V., Ullal, S. D., D’Souza, M. M., Ranade, A. V., Kumar, N. A., & Rai, R. (2025) · 3 Biotech · doi:10.1007/s13205-025-04468-2 · Cited by 64
“Since microglial activation is the hallmark in the etiology of neuroinflammation (Leng and Edison 2021; Heneka et al 2014), among the imaging techniques position emission tomography (PET) is a widely used method to visualize microglial activation.”
Chao, J., Zhang, Y., Du, L., Zhou, R., Wu, X., Shen, K., & Yao, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-11065-8 · Cited by 47
Xia, W., Luo, P., Hua, P., Ding, P., Li, C., Xu, J., Zhou, H., & Gu, Q. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00243 · Cited by 47
Calió, M. L., Mosini, A. C., Marinho, D. S., Salles, G. N., Massinhani, F. H., Ko, G. M., & Porcionatto, M. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105219 · Cited by 47
“Chronic neuroinflammation is also common to nearly all neurodegenerative diseases, and it contributes to their pathophysiology (Heneka et al., 2014).”
Microglia Reactivity Entails Microtubule Remodeling From Acentrosomal to Centrosomal Arrays
Rosito, M., Sanchini, C., Gosti, G., Moreno, M., Panfilis, S. D., Giubettini, M., Debellis, D., Catalano, F., Peruzzi, G., Marotta, R., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2023.112104 · Cited by 46
“2,12 In addition, given the recently identified role for a population of spinal CD11c + microglia in the remission and recurrence of neuropathic pain, 75 it will become critical to determine the contribution of spinal microglial MT dysfunction in the peripheral neuropathy caused by chemotherapeutic…”
Aikawa, T., Mogushi, K., Iijima-Tsutsui, K., Ishikawa, K., Sakurai, M., Tanaka, H., Mizusawa, H., & Watase, K. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv202 · Cited by 51
“inflammatory stimulus can result in neurodegenerative pathology (27).”
Vetreno, R. P., Patel, Y. N., Patel, U., Walter, T. J., & Crews, F. T. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.018 · Cited by 49
“…a developmental sensitivity of 5-HT neurons to LPS. Induction of brain innate immune signals is associated with most neurodegenerative diseases (Heneka et al., 2014), pain and depression (Walker et al., 2014), and alcoholism (Crews et al., 2011; Kelley and Dantzer, 2011), and is extensively…”
BackgroundQuek, H., Luff, J., Cheung, K., Kozlov, S., Gatei, M., Lee, C. S., Bellingham, M. C., Noakes, P. G., Lim, Y. C., Barnett, N. L., et al. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4vma0716-316r · Cited by 46
“Neuroinflammation is a characteristic of many neurodegenerative diseases, including Alzheimer’s disease and amyotrophic lateral sclerosis (motor neuron disease), although it has frequently been assumed to be a consequence rather than a cause of neural disease development and progression [53].”
BackgroundNanoparticle-Based Strategies to Treat Neuro-Inflammation
Poupot, R., Bergozza, D., & Fruchon, S. (2018) · Materials · doi:10.3390/ma11020270 · Cited by 52
“The inflammatory response is a dynamic and organized process which, schematically, takes place in two steps [13]:”
BackgroundGarcía-González, P. A., Cabral‐Miranda, F., Hetz, C. A., & Osorio, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02541 · Cited by 50
Wu, Z., Xiao, L., Wang, H., & Wang, G. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107653 · Cited by 52
Combating neurodegenerative disease with chemical probes and model systems
Narayan, P. S., Ehsani, S., & Lindquist, S. L. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1663 · Cited by 60
Alpha-1 Antitrypsin Attenuates M1 Microglia-Mediated Neuroinflammation in Retinal Degeneration
Zhou, T., Huang, Z., Zhu, X., Sun, X., Liu, Y., Cheng, B., Li, M., Liu, Y., He, C., & Liu, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01202 · Cited by 49
“Neuroinflammation is now recognized as a hallmark of many chronic neurodegenerative disorders and attenuating neuroinflammation has been proved to be a potential therapeutic strategy for these diseases (7, 8).”
BackgroundLiu, Y., Balachandran, Y. L., Li, D., Shao, Y., & Jiang, X. (2016) · ACS Nano · doi:10.1021/acsnano.5b08025 · Cited by 47
Singh, A. K., Mishra, G., Maurya, A., Awasthi, R., Kumari, K., Thakur, A., Rai, A., Rai, G. K., Sharma, B., Kulkarni, G. T., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190903102822 · Cited by 48
Du, J., Liu, D., Zhang, X., Zhou, A., Su, Y., He, D., Fu, S., & Gao, F. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106679 · Cited by 49
Fu, Y., & Jia, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.638772 · Cited by 47
“Previous studies have shown that microglia can be stimulated by fibrillar Aβ to induce the production of TNFα, IL-1β, and IL-6 (Heneka et al., 2014).”
BackgroundInnate Immunity and Cell Death in Alzheimer’s Disease
Lee, S., Cho, H.-J., & Ryu, J.-H. (2021) · ASN Neuro · doi:10.1177/17590914211051908 · Cited by 45
“…PRRs. PRRs drive signal transduction pathways that induce an inflammatory response and secretion of pro-inflammatory cytokines, including type I interferons (IFNs), thereby leading to the microglia-associated clearance of debris via phagocytosis in AD (Heneka et al., 2014; McDonough et al., 2017).”
BackgroundMicroglia Function in the Normal Brain
Rommy von Bernhardi, M., Heredia, F., Salgado, N., & Muñoz, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-40764-7_4 · Cited by 55
Bhatia, H. S., Roelofs, N., Muñoz, E., & Fiebich, B. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-00225-5 · Cited by 41
Fan, L., Qiu, X., Zhu, Z., Lv, J., Lu, J., Mao, F., Zhu, J., Wang, J., Guan, X., Chen, J., et al. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0220-1 · Cited by 47
Yan, S., Xuan, Z., Yang, M., Wang, C., Tao, T., Wang, Q., & Cui, W. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106263 · Cited by 46
Biomarkers of non-communicable chronic disease: an update on contemporary methods
Al‐Hadlaq, S. M., Balto, H. A. G., Hassan, W. M., Marraiki, N., & El-Ansary, A. K. (2022) · PeerJ · doi:10.7717/peerj.12977 · Cited by 58
Exosomes Derived From Mesenchymal Stem Cells: Novel Effects in the Treatment of Ischemic Stroke
Xiong, Y., Song, J., Huang, X., Pan, Z., Goldbrunner, R., Stavrinou, L. C., Lin, S., Hu, W., Zheng, F., & Stavrinou, P. C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.899887 · Cited by 49
Immune-mediated processes in neurodegeneration: where do we stand?
Fakhoury, M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8052-0 · Cited by 43
“Microglia are one of the first cellular components of the innate immune system that gets immunologically active during inflammation [52].”
BackgroundMethodInfluentialRahmani, M., Negro, S., & Barcia, E. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106237 · Cited by 47
Moraes, C. A., Hottz, E. D., Dos Santos Ornellas, D., Adesse, D., de Azevedo, C. T., d’Avila, J. C., Zaverucha-do-Valle, C., Maron-Gutierrez, T., Barbosa, H. S., Bozza, P. T., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03067-z · Cited by 43
Activated microglia trigger inflammasome activation and lysosomal destabilization in human RPE cells
Nebel, C., Aslanidis, A., Rashid, K., & Langmann, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.176 · Cited by 45
Baek, J. Y., Jeong, J. Y., Kim, K. I., Won, S.-Y., Chung, Y. C., Nam, J. H., Cho, E. J., Ahn, T., Bok, E., Shin, W.-H., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113543 · Cited by 42
Motta, C., Finardi, A., Toniolo, S., Lorenzo, F. D., Scaricamazza, E., Loizzo, S., Mercuri, N. B., Furlan, R., Koch, G., & Martorana, A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191250 · Cited by 44
“a detrimental role of neuroinflammation in AD [42], 394 our findings indicate that the specific condition of 395”
Neuroprotective mechanisms of mangiferin in neurodegenerative diseases
Liu, T., Song, Y., & Hu, A. (2021) · Drug Development Research · doi:10.1002/ddr.21783 · Cited by 43
Early intervention attenuates synaptic plasticity impairment and neuroinflammation in 5xFAD mice
Li, K., Wang, X., Jiang, Y., Zhang, X., Liu, Z., Yin, T., & Yang, Z. R. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.007 · Cited by 48
Differential Cytokine-Induced Responses of Polarized Microglia
Chauhan, P., Sheng, W. S., Hu, S., Prasad, S., & Lokensgard, J. R. (2021) · Brain Sciences · doi:10.3390/brainsci11111482 · Cited by 52
Zhong, X., Xie, L., Yang, X., Liang, F., Yang, Y., Tong, J., Zhong, Y., Zhao, K., Tang, Y., & Yuan, C. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00181-3 · Cited by 42
Fu, X., Qin, T., Yu, J., Jiao, J., Ma, Z., Fu, Q., Deng, X., & Ma, S. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666190807160137 · Cited by 42
Wahl, D., Risen, S. J., Osburn, S. C., Emge, T., Sharma, S., Gilberto, V. S., Chatterjee, A., Nagpal, P., Moreno, J. A., & LaRocca, T. J. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03182-9 · Cited by 44
“One key “macro-mechanism” that contributes to both brain aging and tau pathology is neuroinflammation, which is characterized by innate immune signaling, glial cell activation, reduced neuronal health and the release of neurotoxic, pro-inflammatory cytokines [3].”
Current pharmacological developments in 2,3,4′,5-tetrahydroxystilbene 2-O-β-D-glucoside (TSG)
Wu, J., Hu, W., Gong, Y. L., Wang, P., Tong, L., Chen, X., Chen, Z., Xu, X., Yao, W., Zhang, W., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.037 · Cited by 43
Albornoz, E. A., Woodruff, T. M., & Gordon, R. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_3 · Cited by 47
Hydroxytyrosol Decreases LPS- and α-Synuclein-Induced Microglial Activation In Vitro
Gallardo-Fernández, M., Ortega, R. H., Alonso-Bellido, I. M., Rodríguez‐Gómez, J. A., Troncoso, A. M., García-Parrilla, M. C., Venero, J. L., Espinosa‐Oliva, A. M., & de Pablos, R. M. (2019) · Antioxidants · doi:10.3390/antiox9010036 · Cited by 51
“There is also strong evidence supporting that neuroinflammation is a pathological condition present in the central nervous system (CNS) leading to neuronal cell death of patients suffering from PD and AD [2].”
BackgroundChristoforidou, E., Joilin, G., & Hafezparast, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01822-4 · Cited by 48
Dysregulated Brain Cholesterol Metabolism Is Linked to Neuroinflammation in Huntington's Disease
González‐Guevara, E., Cárdenas, G., Pérez‐Severiano, F., & Martínez‐Lazcano, J. C. (2020) · Movement Disorders · doi:10.1002/mds.28089 · Cited by 42
NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
Sita, G., Graziosi, A., Hrelia, P., & Morroni, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136984 · Cited by 44
“Recently, increasing evidence suggests a central role of the immune system in the progression or even the origin of AD [5].”
BackgroundKang, J., Park, M.-C., Lee, E., Jung, J., & Kim, T. (2022) · Biomedicines · doi:10.3390/biomedicines10081824 · Cited by 47
“The prolonged activation of astrocytes and the release of proinflammatory cytokines, chemokines, and reactive oxygen and nitrogen species create a neurotoxic environment, which exacerbates AD progression [61,62].”
BackgroundZhao, M., Deng, L., Lu, X., Fan, L., Zhu, Y., & Zhao, L. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-18146-2 · Cited by 47
“2015), playing a crucial role in neurodegenerative disease development, such as cerebral arteriosclerosis and Parkinson’s disease (Heneka et al. 2014; Sarkar et al. 2017; Libby and Everett 2019; Pirzada et al. 2020).”
BackgroundYstgaard, M. B., Sejersted, Y., Løberg, E. M., Lien, E., Yndestad, A., & Saugstad, O. D. (2015) · Neonatology · doi:10.1159/000437247 · Cited by 44
Le Page, A., Lamoureux, J., Bourgade, K., Frost, E. H., Pawelec, G., Witkowski, J. M., Larbi, A., Dupuis, G., & Fülöp, T. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170124 · Cited by 41
“The fact that AD is now recognized as a systemic disorder [99–101], that there is evidence that inflammatory status is associated with the disease [102] and that there is involvement of the innate and adaptive immune systems [103, 104] converge to highlight these targets in the management of the…”
Microglia in the CNS and Neuropathic Pain
Tsuda, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1756-9_7 · Cited by 44
Herrera-Rivero, M., Santarelli, F., Brosseron, F., Kummer, M. P., & Heneka, M. T. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1540-3 · Cited by 46
Self-citationMitochondrial Dysfunctions: A Thread Sewing Together Alzheimer’s Disease, Diabetes, and Obesity
Rigotto, G., & Basso, E. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7210892 · Cited by 49
“Neuroinflammation has been known for many years to occur in AD: glial cell activation is observed in the proximity of the lesions [20]; moreover, preclinical genetic data have shown that the activation of the immune system contributes to the pathogenesis of the disease [21–23].”
BackgroundThe Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy
Cisternas, P., Taylor, X., & Lasagna‐Reeves, C. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246319 · Cited by 44
Gas6 Inhibits Toll-Like Receptor-Mediated Inflammatory Pathways in Mouse Microglia via Axl and Mer
Gilchrist, S. E., Goudarzi, S., & Hafizi, S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.576650 · Cited by 47
“In inflamed tissue, microglia can control the release of pro-inflammatory cytokines, switching to an anti-inflammatory response to promote healing (Heneka et al., 2014).”
BackgroundGlial Cells and Brain Diseases: Inflammasomes as Relevant Pathological Entities
Mata-Martínez, E., Díaz-Muñoz, M., & Vázquez-Cuevas, F. G. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.929529 · Cited by 41
Finze, A., Biechele, G., Rauchmann, B.-S., Franzmeier, N., Palleis, C., Katzdobler, S., Weidinger, E., Guersel, S., Schuster, S., Harris, S., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02188-8 · Cited by 40
“A β and tau) and their contribution to neuroin fl ammation may provide deeper insight into mechanistic pathways [24].”
BackgroundDe Marco, R., Ronen, I., Branzoli, F., Amato, M. L., Asllani, I., Colasanti, A., Harrison, N. A., & Cercignani, M. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.10.005 · Cited by 40
“However, during neuroinflammation both microglia and astrocytes undergo metabolic, functional and morphological changes (Heneka et al., 2014).”
BackgroundCorraliza-Gómez, M., Bermejo, T., Lilue, J., Rodríguez-Iglesias, N., Valero, J., Cózar‐Castellano, I., Arranz, E. M., Sánchez, D., & Ganfornina, M. D. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02914-7 · Cited by 50
“A previous study shows that Nlrp3 gene deficiency in a mouse model of AD (APP/PS1 mice) increases IDE (both mRNA and protein) with a concomitant modulation of microglial phenotype—increased expression of Arg-1, Fizz1 and Il4, and enhanced Aβ phagocytosis [73].”
BackgroundDadkhah, M., Baziar, M., & Rezaei, N. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156477 · Cited by 44
Palmitoylation of NLRP3 Modulates Inflammasome Activation and Inflammatory Bowel Disease Development
Hu, D., Li, Y., Wang, X., Zou, H., Li, Z., Chen, W., Meng, Y., Wang, Y., Li, Q., Liao, F., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300241 · Cited by 46
Saggu, S., Pless, A., Dew, E., Ware, D., Jiao, K., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1543730 · Cited by 52
“These cytokines exacerbate neurodegeneration and directly disrupt monoamine signaling (221).”
Inflammasomes are neuroprotective targets for sex steroids
Slowik, A., & Beyer, C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.02.013 · Cited by 41
“sequentially triggered by harmful stimuli and traumatic challenges through pathogen-associated molecular patterns (PAMPs) and damage-associated molecular pattern molecules (DAMPs) followed by chemokine and cytokine production and release as will be detailed later [2].”
BackgroundNalbandian, A., Khan, A. A., Srivastava, R., Llewellyn, K. J., Tan, B., Shukr, N., Fazli, Y., Kimonis, V. E., & BenMohamed, L. (2017) · Inflammation · doi:10.1007/s10753-016-0449-5 · Cited by 40
“, NLRP1, NLRP3, NLRC4, and AIM2), the activation of NLRP3 pathway by aberrant host proteins appears to be a common step that contributes to tissue damage and to the development of diverse neurodegenerative disorders [6, 47, 53].”
RetractedOffenburger, S.-L., Ho, X. Y., Tachie-Menson, T., Coakley, S., Hilliard, M. A., & Gartner, A. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007125 · Cited by 41
“Active phagocytic cells in the brain are observed in almost all neurological diseases including Parkinson’s disease (for review [48,49]), as well as in 6-OHDA models of Parkinson’s disease (for review [50]).”
BackgroundKatsumoto, A., de Miranda, A. S., Butovsky, O., Teixeira, A. L., Ransohoff, R. M., & Lamb, B. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1075-y · Cited by 40
“As a result of passage time or environmental factors, microglia and/or peripherally derived monocytes and macrophages may acquire an anti-inflammatory phenotype, which is associated with the increased secretion of neurotrophic factors and enhanced phagocytic activity, which cause them to remove debris and promote rege…”
Hernández, E. R., Sánchez-Maldonado, C., Mayoral, M. Á., Mendieta, L., Alatriste, V., Patricio-Martínez, A., & Limón, I. D. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.02.001 · Cited by 42
Yu, Y., Jiang, X., Fang, X., Wang, Y., Liu, P., Jing, L., Yu, L., Jiang, M., & Tang, C. (2022) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2022.03.011 · Cited by 46
Kılıç, B., Bardakkaya, M., Sağkan, R. I., Aksakal, F., Shakila, S., & Doğruer, D. S. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106322 · Cited by 41
Microglial Activation Imaging Using 18 F-DPA-714 PET/MRI for Detecting Autoimmune Encephalitis
Zhang, M., Meng, H., Zhou, Q., Chunyu, H., He, L., Meng, H., Wang, H., Wang, Y., Sun, C., Xi, Y., et al. (2024) · Radiology · doi:10.1148/radiol.230397 · Cited by 39
Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation
Efremova, L. V., Chovancova, P., Adam, M., Gutbier, S., Schildknecht, S., & Leist, M. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1702-2 · Cited by 50
“Such neurotoxicity was prevented when astrocytes were treated by p38 kinase inhibitors or dexamethasone, whereas such compounds had no effect when added to neurons.”
Background
Metadata
- Authors
- Heneka, M. T., Kummer, M. P., & Latz, E.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- Heneka, Michael T.
- Venue
- Nature Reviews Immunology
- Published
- 2014-06-25
- Volume
- 14
- Issue
- 7
- Pages
- 463-477
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1986611577
- Cited by
- 1,437
- References
- 171
- Citations by year
- 2026: 109 · 2025: 137 · 2024: 118 · 2023: 104 · 2022: 125 · 2021: 143 · 2020: 158 · 2019: 117 · 2018: 116 · 2017: 106 · 2016: 96 · 2015: 97 · 2014: 9
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- innate immunity, neurodegenerative diseases, neuroinflammation, microglia, NLRP3 inflammasome, NOD-like receptors, misfolded proteins, pro-inflammatory mediators, neuronal dysfunction, neuronal cell death, neurodegeneration therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Brain, Carrier Proteins, Humans, Immunity, Innate, Inflammation, Signal Transduction, Cytokines, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Folding, Microglia, Oxidative Stress, Neurodegenerative Diseases, Reactive Nitrogen Species, Receptors, Pattern Recognition, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.